Cargando…

First person – Carmen Hernández-Ainsa

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Carmen Hernández-Ainsa is first author on ‘ Development and characterization of cell models...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906168/
http://dx.doi.org/10.1242/dmm.049434
_version_ 1784665351193100288
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Carmen Hernández-Ainsa is first author on ‘ Development and characterization of cell models harbouring mtDNA deletions for in vitro study of Pearson syndrome’, published in DMM. Carmen is a research assistant in the lab of Eduardo Ruiz-Pesini at Universidad de Zaragoza, Zaragoza, Spain, investigating mitochondrial DNA deletions, pathological consequences and treatments through development of new in vitro models.
format Online
Article
Text
id pubmed-8906168
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-89061682022-03-09 First person – Carmen Hernández-Ainsa Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Carmen Hernández-Ainsa is first author on ‘ Development and characterization of cell models harbouring mtDNA deletions for in vitro study of Pearson syndrome’, published in DMM. Carmen is a research assistant in the lab of Eduardo Ruiz-Pesini at Universidad de Zaragoza, Zaragoza, Spain, investigating mitochondrial DNA deletions, pathological consequences and treatments through development of new in vitro models. The Company of Biologists Ltd 2022-03-01 /pmc/articles/PMC8906168/ http://dx.doi.org/10.1242/dmm.049434 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Carmen Hernández-Ainsa
title First person – Carmen Hernández-Ainsa
title_full First person – Carmen Hernández-Ainsa
title_fullStr First person – Carmen Hernández-Ainsa
title_full_unstemmed First person – Carmen Hernández-Ainsa
title_short First person – Carmen Hernández-Ainsa
title_sort first person – carmen hernández-ainsa
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906168/
http://dx.doi.org/10.1242/dmm.049434